LDL-Cholesterol Targets After the ACC/AHA 2013 Guidelines Evidence That Lower Is Better?

被引：5

作者：

Ben-Yehuda, Ori ^{[1
]}

DeMaria, Anthony N. ^{[2
]}

机构：

[1] Cardiovascu Res Fdn, New York, NY 10022 USA

[2] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 05期

关键词：

guidelines; LDL-cholesterol; LDL-cholesterol goal; statins; DENSITY-LIPOPROTEIN CHOLESTEROL; EVENTS; STATIN; MONOTHERAPY; REDUCTION; EFFICACY; RISK;

D O I：

10.1016/j.jacc.2014.05.020

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：495 / 497

页数：3

共 15 条

[1]

[Anonymous], 1988, ARCH INTERN MED, V148, P1023

[2]

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S [J].

Ballantyne, CM ;

Olsson, AG ;

Cook, TJ ;

Mercuri, MF ;

Pedersen, TR ;

Kjekshus, J .

CIRCULATION, 2001, 104 (25) :3046-3051

[3]

Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy [J].

Berge, KE ;

Ose, L ;

Leren, TP .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) :1094-1100

[4]

Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events A Meta-Analysis of Statin Trials [J].

Boekholdt, S. Matthijs ;

Hovingh, G. Kees ;

Mora, Samia ;

Arsenault, Benoit J. ;

Amarenco, Pierre ;

Pedersen, Terje R. ;

LaRosa, John C. ;

Waters, David D. ;

DeMicco, David A. ;

Simes, R. John ;

Keech, Antony C. ;

Colquhoun, David ;

Hitman, Graham A. ;

Betteridge, John ;

Clearfield, Michael B. ;

Downs, John R. ;

Colhoun, Helen M. ;

Gotto, Antonio M., Jr. ;

Ridker, Paul M. ;

Grundy, Scott M. ;

Kastelein, John J. P. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (05) :485-494

[5]

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes [J].

Cannon, Christopher P. ;

Giugliano, Robert P. ;

Blazing, Michael A. ;

Harrington, Robert A. ;

Peterson, John L. ;

Sisk, Christine McCrary ;

Strony, John ;

Musliner, Thomas A. ;

McCabe, Carolyn H. ;

Veltri, Enrico ;

Braunwald, Eugene ;

Califf, Robert M. .

AMERICAN HEART JOURNAL, 2008, 156 (05) :826-832

[6]

Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[7]

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[8]

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].

Grundy, SM ;

Cleeman, JI ;

Merz, CNB ;

Brewer, HB ;

Clark, LT ;

Hunninghake, DB ;

Pasternak, RC ;

Smith, SC ;

Stone, NJ .

CIRCULATION, 2004, 110 (02) :227-239

[9]

Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin [J].

Hsia, Judith ;

MacFadyen, Jean G. ;

Monyak, John ;

Ridker, Paul M. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (16) :1666-1675

[10]

Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials [J].

Morrone, Doralisa ;

Weintraub, William S. ;

Toth, Peter P. ;

Hanson, Mary E. ;

Lowe, Robert S. ;

Lin, Jianxin ;

Shah, Arvind K. ;

Tershakovec, Andrew M. .

ATHEROSCLEROSIS, 2012, 223 (02) :251-261

← 1 2 →